EC Number   |
Application |
Reference |
|---|
    1.2.1.11 | biotechnology |
development of lysine-overproducing strains |
-, 670165 |
| 1.2.1.11 | biotechnology |
the modofied enzyme with altered substrate specificity using NAD(H) is preferred in biotechnological production of amino acids due to lower costs and higher stability |
742287 |
| 1.2.1.11 | drug development |
ASADH family enzymes are attractive potential targets for development of antibiotics with novel modes of action |
742070 |
| 1.2.1.11 | drug development |
ASADH is a target for the development of novel antibiotics, especially for Gram-negative bacteria that require diaminopimelate for cell-wall biosynthesis |
684158 |
| 1.2.1.11 | drug development |
the enzyme is a validated target for antimicrobial drug design |
-, 741535, 741540 |
| 1.2.1.11 | medicine |
enzyme is a validated drug target |
-, 655821 |
| 1.2.1.11 | medicine |
enzyme is potential target for antimicrobial drugs |
656545 |
| 1.2.1.11 | medicine |
target for antibiotic development |
674667, 675505 |
| 1.2.1.11 | more |
enzyme is an attractive target for development of antibacterial, fungicidal, or herbicidal compounds |
657298 |
| 1.2.1.11 | pharmacology |
enzyme is a target for development of antibiotics |
657153 |
